Cargando…
CDK4: A Novel Therapeutic Target for Extramammary Paget’s Disease
BACKGROUND: The outcome of extramammary Paget’s disease (EMPD) is poor when it progresses to metastasis because of the lack of effective systemic therapies. Recently, CDK4-targeted therapy has attracted attention as a potential therapeutic target for some cancers. The aim of this study was to analyz...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358779/ https://www.ncbi.nlm.nih.gov/pubmed/34395284 http://dx.doi.org/10.3389/fonc.2021.710378 |